EP 3 206 666 B1 relates to liquid pharmaceutical composition comprising pemetrexed.
Brief outline of the case
The opposition was rejected and the opponent appealed.
In-person OP in appeal were scheduled for 08.11.2024.
On 01.11.2024, the opponent withdrew its appeal.
The proprietor requested a different apportionment of costs in its favour.